Fu-Ning Hsu

Dr. Fu-Ning Hsu received her Ph.D. in Life Sciences from National Chung Hsing University in Taiwan. Upon graduation, Dr. Hsu had been a postdoctoral researcher at Texas A&M University Health Science Center from 2012 to 2016. Her research focused on the regulation of androgen receptor in prostate cancer and the drug screening for disorders of lipid metabolism. In 2017, Dr. Hsu joined a startup biotech company, Bionova Scientific, as a Scientist. Dr. Hsu has become a board member and volunteer of Chinese Bioscience Association (CBA) in 2017 as the lead in publications.